No Data
Guardant Health to Present Real-world Data Supporting Performance of Shield Blood Test for Colorectal Cancer Screening at 2024 Digestive Disease Week
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting in Washington, DC, highlighting
Analysts Have Conflicting Sentiments on These Healthcare Companies: AlloVir (ALVR), Guardant Health (GH) and Centessa Pharmaceuticals (CNTA)
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Buy Rating Affirmed for Guardant Health Amid Strong Q1 Performance and Positive Revenue Outlook
After Leaping 31% Guardant Health, Inc. (NASDAQ:GH) Shares Are Not Flying Under The Radar
Guardant Health, Inc. (NASDAQ:GH) shares have had a really impressive month, gaining 31% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since the share price is sti
Analysts Conflicted on These Healthcare Names: Guardant Health (GH), Argenx Se (ARGX) and Annexon Biosciences (ANNX)